Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$1.07B |
| 2 |
Lam Research
LRCX
|
$763M |
| 3 |
Exxon Mobil
XOM
|
$596M |
| 4 |
Merck
MRK
|
$552M |
| 5 |
Arista Networks
ANET
|
$506M |
Top Sells
| 1 |
Broadcom
AVGO
|
$1B |
| 2 |
TSMC
TSM
|
$635M |
| 3 |
AbbVie
ABBV
|
$604M |
| 4 |
Cisco
CSCO
|
$525M |
| 5 |
Goldman Sachs
GS
|
$481M |
Sector Composition
| 1 | Technology | 27.89% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.44% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3851
Nuveen Preferred & Income Opportunities Fund
JPC
$2.61B
| $149K | ﹤0.01% |
19,000
-9,171
| -33% | -$72.1K |
|
3852
Generation Bio
GBIO
$40.3M
| $148K | ﹤0.01% |
139,913
-11,474
| -8% | -$12.2K |
|
3853
Ascent Industries
ACNT
$113M
| $147K | ﹤0.01% |
13,192
| – | – |
|
|
GATO
3854
DELISTED
Gatos Silver, Inc.
GATO
| $147K | ﹤0.01% |
10,531
| – | – |
|
3855
RAPT Therapeutics
RAPT
$196M
| $142K | ﹤0.01% |
90,144
-65
| -0.1% | -$103 |
|
3856
VirTra
VTSI
$66.4M
| $142K | ﹤0.01% |
21,094
+3,022
| +17% | +$20.4K |
|
3857
Anixa Biosciences
ANIX
$99.5M
| $136K | ﹤0.01% |
58,746
+1
| +0% | +$2 |
|
3858
AirSculpt Technologies
AIRS
$392M
| $132K | ﹤0.01% |
25,476
-35,366
| -58% | -$184K |
|
3859
Metagenomi
MGX
$68.3M
| $130K | ﹤0.01% |
+36,091
| New | +$130K |
|
3860
Skye Bioscience
SKYE
$105M
| $127K | ﹤0.01% |
44,908
+1
| +0% | +$3 |
|
3861
PepGen
PEPG
$39.4M
| $127K | ﹤0.01% |
33,487
| – | – |
|
3862
Greenwich LifeSciences
GLSI
$156M
| $126K | ﹤0.01% |
11,203
| – | – |
|
|
NGD
3863
New Gold Inc
NGD
$4.85B
| $125K | ﹤0.01% |
50,292
+5,331
| +12% | +$13.2K |
|
3864
FiscalNote
NOTE
$873M
| $121K | ﹤0.01% |
112,791
| – | – |
|
3865
The ONE Group
STKS
$82.3M
| $119K | ﹤0.01% |
41,053
-24,158
| -37% | -$70.1K |
|
3866
KLX Energy Services
KLXE
$37.6M
| $118K | ﹤0.01% |
23,650
-28,401
| -55% | -$141K |
|
3867
Key Tronic
KTCC
$31.5M
| $118K | ﹤0.01% |
28,238
+1
| +0% | +$4 |
|
|
CLYM
3868
Climb Bio, Inc. Common Stock
CLYM
$151M
| $117K | ﹤0.01% |
64,914
| – | – |
|
|
HIMX
3869
Himax Technologies
HIMX
$1.41B
| $117K | ﹤0.01% |
14,491
-544
| -4% | -$4.37K |
|
3870
Nine Energy Service
NINE
$29.2M
| $116K | ﹤0.01% |
103,594
| – | – |
|
|
AKYA
3871
DELISTED
Akoya BioSciences
AKYA
| $116K | ﹤0.01% |
50,665
-5,717
| -10% | -$13.1K |
|
3872
Emergent Biosolutions
EBS
$438M
| $116K | ﹤0.01% |
12,109
| – | – |
|
3873
Inovio Pharmaceuticals
INO
$137M
| $113K | ﹤0.01% |
61,638
+425
| +0.7% | +$778 |
|
3874
Karyopharm Therapeutics
KPTI
$58.8M
| $112K | ﹤0.01% |
166,317
+1
| +0% | +$1 |
|
|
EQC
3875
DELISTED
Equity Commonwealth
EQC
| $110K | ﹤0.01% |
62,231
-537,327
| -90% | -$951K |
|